Ekspresi Matriks Metalloproteinase-9 Pada Polip Hidung Di Rsup H. Adam Malik Medan
DAFTAR PUSTAKA
Allobid, I; Mullol, J. 2012. “Role of Medical Therapy in the Management of
Nasal Polyps.” Curr Allergy Asthma Rep 12:144–153.
Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology 488 (4) : 323324.
Amalinei, C; Căruntu, I, D; Giuşcă, S, E; Bălan, R, A. 2010. “Matrix
Metalloproteinases involvement in patologic conditions.” Romanian
Journal of Morphology and Embryology 51 (2) : 215-218.
Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal
polyposis.”
American journal of rhinlogy & allergy 25, 291-298.
Assanasen, P; Naclerio, R M. 2001. “ Medical and surgical management
of nasal polyps.” Nasal Polyps
Bachert, C. 2011. “Evidence- based management of nasal polyposis by
intranasal corticosteroid: from the cause to the clinic.” Int arch allergy
immunol, 155:309-321.
Belleguic, C; Corbel, M; Germain, N; Lena, H; Baichot, E; Delaval, P H.
2002. “Increased release of matrix metalloproteinase-9 in the plasma
of acute severe asthmatic patients.” ClinExpAllergy 2002;32:217–23.
Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9
(MMP-9) in
allergic nasal polyps.” Acta histochemica 112 : 92-95.
Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases
(MMPs).
Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007.
“Relationship between matrix metalloproteinases MMP-2, MMP-9,
tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal
polyps.” Allergy volume 62, issue 1, p.66-72.
Cincik, H; Erkul, E; Pinar, D; Ipcioglu, O; Gungor, A; Cekin, E; Cakmak, A.
2013. “Evaluation of MMP-9 and TIMP-1 Levels of the Patients with
Nasal Polyposis After Corticosteroid Therapies.” Indian J Otolaryngol
Head Neck Surg. 2013 Aug; 65(Suppl 2): 445–449.
37
Universitas Sumatera Utara
Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU
Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli,
M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in
nasal polyps.” Italian journal of anatomy and embryology, vol 117, n.
2: 87.
Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008.
The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med
wkly;138 (45-46) : 684-688
Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role
of extracellular matrix metalloproteinases and their inhibitors in
allergic diseases.” Postep derm alergol, XXIX,5:384-389.
Lacroix, J S; Zheng, C G; Goytom, S H; Landis, B; Szalay-Quinodoz, I;
Malis,D D. 2002. “ Histological comparison of nasal polyposis in
black African, Chinese and Caucasian patients.” Rhinology, 40,118121.
Lee, Y M; Kim, S S; Kim, H A; Suh, Y J; Lee, S K; Nahm, D H; Park, H S.
2003. “ Eosinophil inflammation of nasal polyp tissue: Relationships
with matrix metalloproteinases, tissue inhibitor of metalloproteinase1, and transforming growth factor-β1.” J korean med science; 18:97102.
Lechapt-Zalcman, E; Coste, A; d'Ortho, M P; Frisdal, E; Harf, A; Lafuma,
C;
Escudier,
E.
2001.”
Increased
expression
of
matrix
metalloproteinase-9 in nasal polyps.” J pathol 2001 Feb;193(2):23341.
Mudd, P A; Katial, R K; Alam, R; Hohensee, S; Ramakrishnan, V;
Kingdom,
T
T.
2011.”
Variations
in
expression
of
matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in
nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with
nasal polyposis.” Ann Allergy Asthma Immunology.
38
Universitas Sumatera Utara
Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟,
Majalah Kedokteran Nusantara, vol.1, hal. 1-3.
Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s
Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed,
vol 2, p. 1549-1557
Okada, S; Kita, H; George, T J; Gleich, G J; Leiferman, K M. 1997.”
Migration of eosinophils through basement membrane components in
vitro: role of matrix metalloproteinase-9.” AmJRespirCellMolBiol
;17:519–28.
Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010.
“Epidemiologi of nasal polyps in: Nasal polyposis.” Springer- Verlag
Berlin.
Polzehl, D; Moeller, P; Riechielmann, H; Perner, S. 2006. “Distinct
features of chronic rhinosinusitis with and without nasal polyps.”
DOI: 10.1111/j.1398-9995.2006.01132.
Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s
Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1,
p. 525-547
Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008.
“Regulation of matrix metalloproteinases (MMP)-2/-9 expression in
eosinophilic chronic rhinosinusitis- cell culture by interleukin-5 and 13.” In vivo 22:415-422.
Schlosser, R J; Woodworth, B A. 2009. “Chronic Rhinosinusitis and
Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck
Surgery.” BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582.
Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate
semprot hidung dan metil prednisolon oral pada polip hidung dinilai
dari perubahan jumlah sel radang dan stadium polip hidung.”
repository.usu.ac.id/xmlui/handle/123456789/42402.
Shimizu, T; Kanai, K; Asano, K; Hisamitsu, T; Suzaki, H. 2005.
“Suppression of matrix metalloproteinase production in nasal
39
Universitas Sumatera Utara
fibroblasts by tranilast, an antiallergic agent, in vitro.” Mediator
inflamm 14;2005(3):150-9.
Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing
sleep impairment in allergic rhinitis, rhinosinusitis, and nasal
polyposis in: Current medical research and opinions, vol 23, no.9, p.
2135-46.
S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and
their inhibitors in non- neoplastic otorhinolaryngological disease.” The
journal of laryngology and otology 119.6: 436-42.
Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal
polyps.” Allergology International, 54:39-4.
Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of
metalloproteinases MMP-9 in antrochoanal polyps. American Journal
of Rhinology 22 : 339-342
Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012.
“Corelationship between matrix metalloproteinase 2 and 9 expression
and severity of chronic rhinosinusitis with nasal polyposis.” American
journal of rhinology & allergy 26, e1-e4.
Wright, C. 2008. “Medical management of nasal polyposis.” Grand rounds
presentation, UTMB, Dept. Of Otolaryngology.
40
Universitas Sumatera Utara
Allobid, I; Mullol, J. 2012. “Role of Medical Therapy in the Management of
Nasal Polyps.” Curr Allergy Asthma Rep 12:144–153.
Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology 488 (4) : 323324.
Amalinei, C; Căruntu, I, D; Giuşcă, S, E; Bălan, R, A. 2010. “Matrix
Metalloproteinases involvement in patologic conditions.” Romanian
Journal of Morphology and Embryology 51 (2) : 215-218.
Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal
polyposis.”
American journal of rhinlogy & allergy 25, 291-298.
Assanasen, P; Naclerio, R M. 2001. “ Medical and surgical management
of nasal polyps.” Nasal Polyps
Bachert, C. 2011. “Evidence- based management of nasal polyposis by
intranasal corticosteroid: from the cause to the clinic.” Int arch allergy
immunol, 155:309-321.
Belleguic, C; Corbel, M; Germain, N; Lena, H; Baichot, E; Delaval, P H.
2002. “Increased release of matrix metalloproteinase-9 in the plasma
of acute severe asthmatic patients.” ClinExpAllergy 2002;32:217–23.
Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9
(MMP-9) in
allergic nasal polyps.” Acta histochemica 112 : 92-95.
Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases
(MMPs).
Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007.
“Relationship between matrix metalloproteinases MMP-2, MMP-9,
tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal
polyps.” Allergy volume 62, issue 1, p.66-72.
Cincik, H; Erkul, E; Pinar, D; Ipcioglu, O; Gungor, A; Cekin, E; Cakmak, A.
2013. “Evaluation of MMP-9 and TIMP-1 Levels of the Patients with
Nasal Polyposis After Corticosteroid Therapies.” Indian J Otolaryngol
Head Neck Surg. 2013 Aug; 65(Suppl 2): 445–449.
37
Universitas Sumatera Utara
Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU
Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli,
M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in
nasal polyps.” Italian journal of anatomy and embryology, vol 117, n.
2: 87.
Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008.
The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med
wkly;138 (45-46) : 684-688
Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role
of extracellular matrix metalloproteinases and their inhibitors in
allergic diseases.” Postep derm alergol, XXIX,5:384-389.
Lacroix, J S; Zheng, C G; Goytom, S H; Landis, B; Szalay-Quinodoz, I;
Malis,D D. 2002. “ Histological comparison of nasal polyposis in
black African, Chinese and Caucasian patients.” Rhinology, 40,118121.
Lee, Y M; Kim, S S; Kim, H A; Suh, Y J; Lee, S K; Nahm, D H; Park, H S.
2003. “ Eosinophil inflammation of nasal polyp tissue: Relationships
with matrix metalloproteinases, tissue inhibitor of metalloproteinase1, and transforming growth factor-β1.” J korean med science; 18:97102.
Lechapt-Zalcman, E; Coste, A; d'Ortho, M P; Frisdal, E; Harf, A; Lafuma,
C;
Escudier,
E.
2001.”
Increased
expression
of
matrix
metalloproteinase-9 in nasal polyps.” J pathol 2001 Feb;193(2):23341.
Mudd, P A; Katial, R K; Alam, R; Hohensee, S; Ramakrishnan, V;
Kingdom,
T
T.
2011.”
Variations
in
expression
of
matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in
nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with
nasal polyposis.” Ann Allergy Asthma Immunology.
38
Universitas Sumatera Utara
Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟,
Majalah Kedokteran Nusantara, vol.1, hal. 1-3.
Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s
Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed,
vol 2, p. 1549-1557
Okada, S; Kita, H; George, T J; Gleich, G J; Leiferman, K M. 1997.”
Migration of eosinophils through basement membrane components in
vitro: role of matrix metalloproteinase-9.” AmJRespirCellMolBiol
;17:519–28.
Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010.
“Epidemiologi of nasal polyps in: Nasal polyposis.” Springer- Verlag
Berlin.
Polzehl, D; Moeller, P; Riechielmann, H; Perner, S. 2006. “Distinct
features of chronic rhinosinusitis with and without nasal polyps.”
DOI: 10.1111/j.1398-9995.2006.01132.
Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s
Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1,
p. 525-547
Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008.
“Regulation of matrix metalloproteinases (MMP)-2/-9 expression in
eosinophilic chronic rhinosinusitis- cell culture by interleukin-5 and 13.” In vivo 22:415-422.
Schlosser, R J; Woodworth, B A. 2009. “Chronic Rhinosinusitis and
Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck
Surgery.” BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582.
Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate
semprot hidung dan metil prednisolon oral pada polip hidung dinilai
dari perubahan jumlah sel radang dan stadium polip hidung.”
repository.usu.ac.id/xmlui/handle/123456789/42402.
Shimizu, T; Kanai, K; Asano, K; Hisamitsu, T; Suzaki, H. 2005.
“Suppression of matrix metalloproteinase production in nasal
39
Universitas Sumatera Utara
fibroblasts by tranilast, an antiallergic agent, in vitro.” Mediator
inflamm 14;2005(3):150-9.
Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku
Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing
sleep impairment in allergic rhinitis, rhinosinusitis, and nasal
polyposis in: Current medical research and opinions, vol 23, no.9, p.
2135-46.
S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and
their inhibitors in non- neoplastic otorhinolaryngological disease.” The
journal of laryngology and otology 119.6: 436-42.
Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal
polyps.” Allergology International, 54:39-4.
Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of
metalloproteinases MMP-9 in antrochoanal polyps. American Journal
of Rhinology 22 : 339-342
Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012.
“Corelationship between matrix metalloproteinase 2 and 9 expression
and severity of chronic rhinosinusitis with nasal polyposis.” American
journal of rhinology & allergy 26, e1-e4.
Wright, C. 2008. “Medical management of nasal polyposis.” Grand rounds
presentation, UTMB, Dept. Of Otolaryngology.
40
Universitas Sumatera Utara